Financial Ratios

MONOZYME INDIA LTD.

NSE : NABSE : 522199ISIN CODE : INE772D01028Industry : Hospital & Healthcare ServicesHouse : Private
BSE4.410 (0 %)
PREV CLOSE ( ) 4.41
OPEN PRICE ( ) 4.41
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 4.00 (1550)
VOLUME 25
TODAY'S LOW / HIGH ( )4.41 4.41
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2008Mar2007Mar2006Mar2005Mar2004
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.28-2.091.060.411.18
   CEPS(Rs)-0.12-1.890.660.320.70
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)2.262.549.268.197.79
   Tax Rate(%)-0.85-7.2235.3250.4126.54
Margin Ratios
   Core EBITDA Margin(%)-4213.77-13.048.366.407.18
   EBIT Margin(%)580.23-14.338.105.936.81
   Pre Tax Margin(%)-502.19-23.984.672.593.86
   PAT Margin (%)-506.44-25.723.021.282.84
   Cash Profit Margin (%)-219.67-23.193.732.023.36
Performance Ratios
   ROA(%)-2.71-13.563.421.443.84
   ROE(%)-11.67-58.4012.215.0716.58
   ROCE(%)3.76-9.8413.2811.4119.19
   Asset Turnover(x)0.010.531.131.121.35
   Sales/Fixed Asset(x)0.023.477.867.499.92
   Working Capital/Sales(x)0.011.071.752.363.17
Efficiency Ratios
   Fixed Capital/Sales(x)40.150.290.130.130.10
   Receivable days0.00359.07163.15175.80123.54
   Inventory Days0.00130.9569.4278.6965.46
   Payable days84.37178.28175.50253.17182.65
Valuation Parameters
   PER(x)0.000.007.5823.452.05
   PCE(x)-30.49-2.5212.2829.873.46
   Price/Book(x)1.641.871.742.320.62
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)145.211.550.920.870.29
   EV/Core EBITDA(x)16.75-13.1710.0212.523.80
   EV/EBIT(x)25.03-10.8410.8914.064.09
   EV/CE(x)1.030.990.861.000.39
   M Cap / Sales66.990.580.480.630.12
Growth Ratio
   Net Sales Growth(%)-99.32-51.9812.06-25.0328.66
   Core EBITDA Growth(%)149.86-161.9047.79-31.2557.66
   EBIT Growth(%)127.48-181.7552.66-34.0963.07
   PAT Growth(%)86.63-493.07163.28-65.79132.62
   EPS Growth(%)86.63-296.53162.86-65.79132.62
Financial Stability Ratios
   Total Debt/Equity(x)1.933.121.861.011.10
   Current Ratio(x)7.774.533.162.421.99
   Quick Ratio(x)7.773.562.361.791.41
   Interest Cover(x)0.54-1.492.361.772.31
   Total Debt/Mcap(x)1.151.631.040.421.72

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.